Protara Therapeutics Inc.

NASDAQ: TARA · Real-Time Price · USD
3.03
-0.16 (-5.02%)
At close: Aug 15, 2025, 3:59 PM
3.09
1.98%
After-hours: Aug 15, 2025, 07:48 PM EDT

Protara Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-44.6M -40.42M -65.95M -47.25M
Depreciation & Amortization
332K 341K 248K 117K
Stock-Based Compensation
4.13M 6.09M 6.69M 10.36M
Other Working Capital
2.63M -4.99M -92K 494K
Other Non-Cash Items
324K 569K 32.02M 1.74M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
4.01M -4.14M 539K 534K
Operating Cash Flow
-35.81M -37.56M -26.46M -34.5M
Capital Expenditures
-63K -45K -120K -596K
Cash Acquisitions
n/a n/a -15.07K 97.6K
Purchase of Investments
-29.38M -12.19M -43.55M -124.75M
Sales Maturities Of Investments
48.6M 65.34M 58.62M 27.15M
Other Investing Acitivies
n/a n/a 15.07K -97.6K
Investing Cash Flow
19.16M 53.11M 14.95M -98.19M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -91K -90K -228K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.86M n/a n/a n/a
Financial Cash Flow
139.87M -91K -90K -228K
Net Cash Flow
123.21M 15.46M -11.6M -132.92M
Free Cash Flow
-35.87M -37.6M -26.58M -35.1M